Dr. Reddys Laboratories Ltd.

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) on October 20, 2025 for its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh, India. 

The United States Food & Drug Administration (USFDA) has classified the inspection outcome as 'Voluntary Action Indicated (VAI)' and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.